Inflammation in the development of lung cancer: epidemiological evidence.
about
Potential role of chitinase 3-like-1 in inflammation-associated carcinogenic changes of epithelial cellsEpidemic of lung cancer in patients with HIV infectionBacterial and fungal microflora in surgically removed lung cancer samplesIdentification of a microRNA signature associated with progression of leukoplakia to oral carcinomaTag SNPs in complement receptor-1 contribute to the susceptibility to non-small cell lung cancerPromotion of a cancer-like phenotype, through chronic exposure to inflammatory cytokines and hypoxia in a bronchial epithelial cell line modelPrevious lung diseases and lung cancer risk: a systematic review and meta-analysisCombining COPD with clinical, pathological and demographic information refines prognosis and treatment response prediction of non-small cell lung cancerPrevious lung diseases and lung cancer risk: a pooled analysis from the International Lung Cancer ConsortiumSerum biomarkers of polyomavirus infection and risk of lung cancer in never smokersDetection of Merkel cell polyomavirus with a tumour-specific signature in non-small cell lung cancerKnockout of the tumor suppressor gene Gprc5a in mice leads to NF-kappaB activation in airway epithelium and promotes lung inflammation and tumorigenesisAsthma and lung cancer risk: a systematic investigation by the International Lung Cancer ConsortiumProstatic stones: evidence of a specific chemistry related to infection and presence of bacterial imprintsThe human disease network in terms of dysfunctional regulatory mechanismsChronic obstructive pulmonary disease and altered risk of lung cancer in a population-based case-control study.The complexity of HIV persistence and pathogenesis in the lung under antiretroviral therapy: challenges beyond AIDS.Lower risk of lung cancer after multiple pneumonia diagnoses.Transcriptional profiling of the acute pulmonary inflammatory response induced by LPS: role of neutrophils.Vanadium pentoxide induces pulmonary inflammation and tumor promotion in a strain-dependent manner.Pulmonary tuberculosis and lung cancer: simultaneous and sequential occurrence.De novo malignancy in organ transplant recipients in Taiwan: a nationwide cohort population studyLung cancer risk following detection of pulmonary scarring by chest radiography in the prostate, lung, colorectal, and ovarian cancer screening trial.Smoking and lung cancer: the role of inflammation.C-reactive protein and risk of lung cancer.Cigarette smoke, bacteria, mold, microbial toxins, and chronic lung inflammationSingle nucleotide polymorphisms of 8 inflammation-related genes and their associations with smoking-related cancers.Carbon dioxide is largely responsible for the acute inflammatory effects of tobacco smoke.A review of the application of inflammatory biomarkers in epidemiologic cancer research.Helicobacter pylori seropositivity and risk of lung cancer.Pulmonary infections and risk of lung cancer among persons with AIDS.Lung cancer incidence and mortality among HIV-infected and HIV-uninfected injection drug usersC-reactive protein, interleukin 6 and lung cancer risk: a meta-analysisRecent trends and future directions in human immunodeficiency virus-associated cancer.Second malignancy risks after non-Hodgkin's lymphoma and chronic lymphocytic leukemia: differences by lymphoma subtypeCumulative incidence of cancer after solid organ transplantationRacial/ethnic differences in cancer risk after kidney transplantation.Noninfectious pulmonary complications of human immunodeficiency virus infectionSerum p53 antibody detection in patients with impaired lung function.Cumulative incidence of cancer among individuals with acquired immunodeficiency syndrome in the United States
P2860
Q24656942-201A2B07-F8C1-40DD-B9D4-C580A0226470Q27000028-76B41F77-9E37-45F8-8129-6B165B324C9AQ27498974-DDAF5EE1-4EC0-4FAD-ADDA-76564EE0FE89Q28259466-C66AAB72-F9B8-409D-9BD4-FFCC0968054AQ28384476-72CB9230-50E5-4C24-9916-EA12C3DDD37DQ28384920-10AE2C02-91A8-4984-9510-5F335377000CQ28387390-573926E9-0692-4617-BD54-ECF88A7C9B6BQ28388778-3CB25627-9FE8-4E8F-A906-C31ED3BBC6ECQ28392363-3964D2E8-BDA1-4623-AE1B-EF0EABDC0D72Q28394577-FB728AA4-025B-40D2-8C18-C91743881818Q28395413-4936033F-C889-4484-8AC7-CCA96C8A87E5Q28396291-5C1F58A6-20BE-456E-90DD-05BC45503E13Q28397184-B0318ECE-0CBD-48C4-9335-90EBC39348BBQ28484337-9AD2ACF8-A7DC-4650-B63C-80F98D981758Q28550156-8335BA56-5B21-44DA-A66C-06B90C9D690BQ33509281-5B4211F3-2521-4014-B21C-D15EFA70675CQ33705883-250E63BA-0CF8-4372-86AC-0FA5CBCD4389Q33723442-7F0E41EA-EE56-47CB-A351-06FEB06C8843Q33728845-BE9D7D76-9607-4953-8993-C91730C72A2AQ33816019-1C6907FB-EC1F-4ACF-8B1C-32A312E8F29AQ33824133-48C2FAE4-D009-45B6-BE0E-5BBC777E9895Q33829612-FC8CF100-7ECD-4DC6-A6F5-636B3849A3FBQ33837125-0CEB15E3-EC17-4061-BA1C-6C46FFC93842Q33842487-DFD0EFD3-A324-49E6-A08A-50CFBDD17F34Q33898168-1D88EE28-42D2-435D-91D2-A75E9947118DQ33965983-3D3953DD-B837-48DB-8324-01577E974F22Q34101144-6A57CC61-E2F2-44AD-9CD0-7DADDFADCACDQ34109909-AC205C87-5837-48FD-8E8D-9F1342747FF4Q34135803-A5AD7F6D-F022-4DD3-A1ED-190573CE8546Q34182270-EBEB95DB-ED20-43EC-9E2D-284803E69B25Q34203687-05806079-EF14-4438-BD81-A4E7AD620A1CQ34283403-5DF97A29-0242-422E-B4B8-1FC5B5A791A3Q34389236-90395993-3929-4F8D-A943-4EDC945AB03FQ34433592-AD44AC24-8F61-497E-9D91-66E9246D3935Q34488720-6563647B-BC65-4BB9-BE13-8A663F18C6FDQ34561525-A9D21CF3-2CEB-4F13-A22A-294C383374F6Q34562594-0D51931E-6E02-4A52-940B-53565843D81FQ34564288-3B07F954-C36C-470E-BF78-B771FFF313F8Q34577526-F95495B1-D375-431C-ABBD-FAE19E1BF345Q34643410-86C7BB2F-1799-48DD-BD4D-7793E17E6D90
P2860
Inflammation in the development of lung cancer: epidemiological evidence.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Inflammation in the development of lung cancer: epidemiological evidence.
@en
Inflammation in the development of lung cancer: epidemiological evidence.
@nl
type
label
Inflammation in the development of lung cancer: epidemiological evidence.
@en
Inflammation in the development of lung cancer: epidemiological evidence.
@nl
prefLabel
Inflammation in the development of lung cancer: epidemiological evidence.
@en
Inflammation in the development of lung cancer: epidemiological evidence.
@nl
P2860
P356
P1476
Inflammation in the development of lung cancer: epidemiological evidence.
@en
P2093
Eric A Engels
P2860
P304
P356
10.1586/14737140.8.4.605
P577
2008-04-01T00:00:00Z